_id
695fba2ac2e91020a7bd430b
Ticker
0JDM.LSE
Name
IQVIA Holdings Inc.
Exchange
LSE
Address
2400 Ellis Road, Durham, NC, United States, 27703
Country
UK
Sector
Industry
Currency
USD
Website
https://www.iqvia.com
Description
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.
Last Close
240.53
Volume
204
Current Price
245.61
Change
1.8817
Last Updated
2026-01-08T14:07:38.679Z
Ipo Date
-
Market Cap
4757654732800
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
4100000000
Cost Of Revenue
2727000000
Gross Profit
1373000000
Operating Expenses
820000000
Operating Income
553000000
Interest Expense
189000000
Pretax Income
408000000
Net Income
331000000
Eps
1.9277810133954572
Dividends Per Share
-
Shares Outstanding
202306000
Income Tax Expense
76000000
EBITDA
883000000
Operating Margin
13.487804878048781
Total Other Income Expense Net
-145000000
Cash
1814000000
Short Term Investments
158000000
Receivables
3314000000
Inventories
-
Total Current Assets
5979000000
Property Plant Equipment
824000000
Total Assets
28727000000
Payables
3550000000
Short Term Debt
2164000000
Long Term Debt
-
Total Liabilities
22439000000
Equity
6160000000
Bs_currency_symbol
-
Depreciation
286000000
Change In Working Capital
452000000
Cash From Operations
908000000
Capital Expenditures
293000000
Cash From Investing
-550000000
Cash From Financing
-572000000
Net Change In Cash
-225000000
Cf_currency_symbol
-
PE
0.4311
PB
6.845980032467533
ROE
5.373376623376623
ROA
1.1522261287290703
FCF
615000000
Fcf Percent
0.15
Piotroski FScore
4
Health Score
44
Deep Value Investing Score
6
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
5
Growth Investing Score
4.5
Momentum Investing Score
6
Net Net Investing Score
3.5
Quality Investing Score
4.5
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
4100000000
Quarters > 0 > income Statement > cost Of Revenue
2727000000
Quarters > 0 > income Statement > gross Profit
1373000000
Quarters > 0 > income Statement > operating Expenses
820000000
Quarters > 0 > income Statement > operating Income
553000000
Quarters > 0 > income Statement > interest Expense
189000000
Quarters > 0 > income Statement > pretax Income
408000000
Quarters > 0 > income Statement > net Income
331000000
Quarters > 0 > income Statement > eps
1.9277810133954572
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
171700000
Quarters > 0 > income Statement > income Tax Expense
76000000
Quarters > 0 > income Statement > EBITDA
883000000
Quarters > 0 > income Statement > operating Margin
13.487804878048781
Quarters > 0 > income Statement > total Other Income Expense Net
-145000000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1814000000
Quarters > 0 > balance Sheet > short Term Investments
158000000
Quarters > 0 > balance Sheet > receivables
3314000000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
5979000000
Quarters > 0 > balance Sheet > property Plant Equipment
824000000
Quarters > 0 > balance Sheet > total Assets
28727000000
Quarters > 0 > balance Sheet > payables
3550000000
Quarters > 0 > balance Sheet > short Term Debt
2164000000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
22439000000
Quarters > 0 > balance Sheet > equity
6160000000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
332000000
Quarters > 0 > cash Flow > depreciation
286000000
Quarters > 0 > cash Flow > change In Working Capital
452000000
Quarters > 0 > cash Flow > cash From Operations
908000000
Quarters > 0 > cash Flow > capital Expenditures
293000000
Quarters > 0 > cash Flow > cash From Investing
-550000000
Quarters > 0 > cash Flow > cash From Financing
-572000000
Quarters > 0 > cash Flow > net Change In Cash
-225000000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
1.9277810133954572
Quarters > 0 > ratios > PB
6.845980032467533
Quarters > 0 > ratios > ROE
5.373376623376623
Quarters > 0 > ratios > ROA
1.1522261287290703
Quarters > 0 > ratios > FCF
615000000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.15
Quarters > 0 > health Score
44
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
4017000000
Quarters > 1 > income Statement > cost Of Revenue
2694000000
Quarters > 1 > income Statement > gross Profit
1323000000
Quarters > 1 > income Statement > operating Expenses
817000000
Quarters > 1 > income Statement > operating Income
506000000
Quarters > 1 > income Statement > interest Expense
182000000
Quarters > 1 > income Statement > pretax Income
323000000
Quarters > 1 > income Statement > net Income
266000000
Quarters > 1 > income Statement > eps
1.535796766743649
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
173200000
Quarters > 1 > income Statement > income Tax Expense
57000000
Quarters > 1 > income Statement > EBITDA
781000000
Quarters > 1 > income Statement > operating Margin
12.59646502364949
Quarters > 1 > income Statement > total Other Income Expense Net
-183000000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
2039000000
Quarters > 1 > balance Sheet > short Term Investments
149000000
Quarters > 1 > balance Sheet > receivables
3406000000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
6345000000
Quarters > 1 > balance Sheet > property Plant Equipment
816000000
Quarters > 1 > balance Sheet > total Assets
28632000000
Quarters > 1 > balance Sheet > payables
3399000000
Quarters > 1 > balance Sheet > short Term Debt
1313000000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
22846000000
Quarters > 1 > balance Sheet > equity
5778000000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
266000000
Quarters > 1 > cash Flow > depreciation
276000000
Quarters > 1 > cash Flow > change In Working Capital
-104000000
Quarters > 1 > cash Flow > cash From Operations
443000000
Quarters > 1 > cash Flow > capital Expenditures
151000000
Quarters > 1 > cash Flow > cash From Investing
-346000000
Quarters > 1 > cash Flow > cash From Financing
145000000
Quarters > 1 > cash Flow > net Change In Cash
299000000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
1.535796766743649
Quarters > 1 > ratios > PB
7.362348909657322
Quarters > 1 > ratios > ROE
4.603669089650398
Quarters > 1 > ratios > ROA
0.9290304554344789
Quarters > 1 > ratios > FCF
292000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.07269106298232512
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
3829000000
Quarters > 2 > income Statement > cost Of Revenue
2531000000
Quarters > 2 > income Statement > gross Profit
1298000000
Quarters > 2 > income Statement > operating Expenses
802000000
Quarters > 2 > income Statement > operating Income
496000000
Quarters > 2 > income Statement > interest Expense
165000000
Quarters > 2 > income Statement > pretax Income
310000000
Quarters > 2 > income Statement > net Income
249000000
Quarters > 2 > income Statement > eps
1.403607666290868
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
177400000
Quarters > 2 > income Statement > income Tax Expense
61000000
Quarters > 2 > income Statement > EBITDA
753000000
Quarters > 2 > income Statement > operating Margin
12.953773831287544
Quarters > 2 > income Statement > total Other Income Expense Net
-186000000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1740000000
Quarters > 2 > balance Sheet > short Term Investments
136000000
Quarters > 2 > balance Sheet > receivables
3311000000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
5911000000
Quarters > 2 > balance Sheet > property Plant Equipment
768000000
Quarters > 2 > balance Sheet > total Assets
27322000000
Quarters > 2 > balance Sheet > payables
3559000000
Quarters > 2 > balance Sheet > short Term Debt
1222000000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
21337000000
Quarters > 2 > balance Sheet > equity
5977000000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
249000000
Quarters > 2 > cash Flow > depreciation
265000000
Quarters > 2 > cash Flow > change In Working Capital
4000000
Quarters > 2 > cash Flow > cash From Operations
568000000
Quarters > 2 > cash Flow > capital Expenditures
142000000
Quarters > 2 > cash Flow > cash From Investing
-305000000
Quarters > 2 > cash Flow > cash From Financing
-258000000
Quarters > 2 > cash Flow > net Change In Cash
38000000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
1.403607666290868
Quarters > 2 > ratios > PB
7.289813284256316
Quarters > 2 > ratios > ROE
4.165969549941442
Quarters > 2 > ratios > ROA
0.911353488031623
Quarters > 2 > ratios > FCF
426000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.11125620266388091
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
3958000000
Quarters > 3 > income Statement > cost Of Revenue
2580000000
Quarters > 3 > income Statement > gross Profit
1378000000
Quarters > 3 > income Statement > operating Expenses
752000000
Quarters > 3 > income Statement > operating Income
626000000
Quarters > 3 > income Statement > interest Expense
171000000
Quarters > 3 > income Statement > pretax Income
549000000
Quarters > 3 > income Statement > net Income
437000000
Quarters > 3 > income Statement > eps
2.4170353982300883
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
180800000
Quarters > 3 > income Statement > income Tax Expense
112000000
Quarters > 3 > income Statement > EBITDA
1018000000
Quarters > 3 > income Statement > operating Margin
15.816068721576555
Quarters > 3 > income Statement > total Other Income Expense Net
-77000000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1702000000
Quarters > 3 > balance Sheet > short Term Investments
141000000
Quarters > 3 > balance Sheet > receivables
3240000000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5829000000
Quarters > 3 > balance Sheet > property Plant Equipment
773000000
Quarters > 3 > balance Sheet > total Assets
26899000000
Quarters > 3 > balance Sheet > payables
736000000
Quarters > 3 > balance Sheet > short Term Debt
1145000000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
20832000000
Quarters > 3 > balance Sheet > equity
6067000000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
437000000
Quarters > 3 > cash Flow > depreciation
303000000
Quarters > 3 > cash Flow > change In Working Capital
105000000
Quarters > 3 > cash Flow > cash From Operations
885000000
Quarters > 3 > cash Flow > capital Expenditures
164000000
Quarters > 3 > cash Flow > cash From Investing
-310000000
Quarters > 3 > cash Flow > cash From Financing
-375000000
Quarters > 3 > cash Flow > net Change In Cash
130000000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
2.4170353982300883
Quarters > 3 > ratios > PB
7.319315641997693
Quarters > 3 > ratios > ROE
7.202900939508818
Quarters > 3 > ratios > ROA
1.6245957098776904
Quarters > 3 > ratios > FCF
721000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.18216270843860535
Quarters > 3 > health Score
49
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
15405000000
Annuals > 0 > income Statement > cost Of Revenue
10030000000
Annuals > 0 > income Statement > gross Profit
5375000000
Annuals > 0 > income Statement > operating Expenses
3173000000
Annuals > 0 > income Statement > operating Income
2202000000
Annuals > 0 > income Statement > interest Expense
670000000
Annuals > 0 > income Statement > pretax Income
1669000000
Annuals > 0 > income Statement > net Income
1373000000
Annuals > 0 > income Statement > eps
7.486368593238822
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
183400000
Annuals > 0 > income Statement > income Tax Expense
296000000
Annuals > 0 > income Statement > EBITDA
3453000000
Annuals > 0 > income Statement > operating Margin
14.294060370009737
Annuals > 0 > income Statement > total Other Income Expense Net
-533000000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
1702000000
Annuals > 0 > balance Sheet > short Term Investments
141000000
Annuals > 0 > balance Sheet > receivables
3240000000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5829000000
Annuals > 0 > balance Sheet > property Plant Equipment
773000000
Annuals > 0 > balance Sheet > total Assets
26899000000
Annuals > 0 > balance Sheet > payables
736000000
Annuals > 0 > balance Sheet > short Term Debt
1145000000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
20832000000
Annuals > 0 > balance Sheet > equity
6067000000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
1373000000
Annuals > 0 > cash Flow > depreciation
1114000000
Annuals > 0 > cash Flow > change In Working Capital
158000000
Annuals > 0 > cash Flow > cash From Operations
2716000000
Annuals > 0 > cash Flow > capital Expenditures
602000000
Annuals > 0 > cash Flow > cash From Investing
-1444000000
Annuals > 0 > cash Flow > cash From Financing
-878000000
Annuals > 0 > cash Flow > net Change In Cash
326000000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
7.486368593238822
Annuals > 0 > ratios > PB
7.424571287291907
Annuals > 0 > ratios > ROE
22.630624690951045
Annuals > 0 > ratios > ROA
5.104278969478419
Annuals > 0 > ratios > FCF
2114000000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.13722817267121065
Annuals > 0 > health Score
57
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
14984000000
Annuals > 1 > income Statement > cost Of Revenue
9745000000
Annuals > 1 > income Statement > gross Profit
5239000000
Annuals > 1 > income Statement > operating Expenses
3262000000
Annuals > 1 > income Statement > operating Income
1977000000
Annuals > 1 > income Statement > interest Expense
672000000
Annuals > 1 > income Statement > pretax Income
1459000000
Annuals > 1 > income Statement > net Income
1358000000
Annuals > 1 > income Statement > eps
7.289318303811058
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
186300000
Annuals > 1 > income Statement > income Tax Expense
101000000
Annuals > 1 > income Statement > EBITDA
3256000000
Annuals > 1 > income Statement > operating Margin
13.194073678590495
Annuals > 1 > income Statement > total Other Income Expense Net
-518000000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
1376000000
Annuals > 1 > balance Sheet > short Term Investments
120000000
Annuals > 1 > balance Sheet > receivables
3413000000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
5596000000
Annuals > 1 > balance Sheet > property Plant Equipment
819000000
Annuals > 1 > balance Sheet > total Assets
26681000000
Annuals > 1 > balance Sheet > payables
709000000
Annuals > 1 > balance Sheet > short Term Debt
718000000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
20569000000
Annuals > 1 > balance Sheet > equity
6112000000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
1358000000
Annuals > 1 > cash Flow > depreciation
1125000000
Annuals > 1 > cash Flow > change In Working Capital
-280000000
Annuals > 1 > cash Flow > cash From Operations
2149000000
Annuals > 1 > cash Flow > capital Expenditures
649000000
Annuals > 1 > cash Flow > cash From Investing
-1603000000
Annuals > 1 > cash Flow > cash From Financing
-382000000
Annuals > 1 > cash Flow > net Change In Cash
160000000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
7.289318303811058
Annuals > 1 > ratios > PB
7.486443553664922
Annuals > 1 > ratios > ROE
22.218586387434556
Annuals > 1 > ratios > ROA
5.089764251714703
Annuals > 1 > ratios > FCF
1500000000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.100106780565937
Annuals > 1 > health Score
54
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
14410000000
Annuals > 2 > income Statement > cost Of Revenue
9382000000
Annuals > 2 > income Statement > gross Profit
5028000000
Annuals > 2 > income Statement > operating Expenses
3229000000
Annuals > 2 > income Statement > operating Income
1799000000
Annuals > 2 > income Statement > interest Expense
416000000
Annuals > 2 > income Statement > pretax Income
1351000000
Annuals > 2 > income Statement > net Income
1091000000
Annuals > 2 > income Statement > eps
5.724029380902413
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
190600000
Annuals > 2 > income Statement > income Tax Expense
260000000
Annuals > 2 > income Statement > EBITDA
2909000000
Annuals > 2 > income Statement > operating Margin
12.48438584316447
Annuals > 2 > income Statement > total Other Income Expense Net
-448000000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
1216000000
Annuals > 2 > balance Sheet > short Term Investments
93000000
Annuals > 2 > balance Sheet > receivables
2960000000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
4981000000
Annuals > 2 > balance Sheet > property Plant Equipment
863000000
Annuals > 2 > balance Sheet > total Assets
25337000000
Annuals > 2 > balance Sheet > payables
645000000
Annuals > 2 > balance Sheet > short Term Debt
152000000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
19572000000
Annuals > 2 > balance Sheet > equity
5765000000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
1091000000
Annuals > 2 > cash Flow > depreciation
1130000000
Annuals > 2 > cash Flow > change In Working Capital
-84000000
Annuals > 2 > cash Flow > cash From Operations
2260000000
Annuals > 2 > cash Flow > capital Expenditures
674000000
Annuals > 2 > cash Flow > cash From Investing
-2006000000
Annuals > 2 > cash Flow > cash From Financing
-329000000
Annuals > 2 > cash Flow > net Change In Cash
-150000000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
5.724029380902413
Annuals > 2 > ratios > PB
8.120254293148308
Annuals > 2 > ratios > ROE
18.924544666088465
Annuals > 2 > ratios > ROA
4.305955716935707
Annuals > 2 > ratios > FCF
1586000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.11006245662734213
Annuals > 2 > health Score
53
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
13874000000
Annuals > 3 > income Statement > cost Of Revenue
9233000000
Annuals > 3 > income Statement > gross Profit
4641000000
Annuals > 3 > income Statement > operating Expenses
3248000000
Annuals > 3 > income Statement > operating Income
1393000000
Annuals > 3 > income Statement > interest Expense
375000000
Annuals > 3 > income Statement > pretax Income
1134000000
Annuals > 3 > income Statement > net Income
966000000
Annuals > 3 > income Statement > eps
4.953846153846154
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
195000000
Annuals > 3 > income Statement > income Tax Expense
163000000
Annuals > 3 > income Statement > EBITDA
2767000000
Annuals > 3 > income Statement > operating Margin
10.040363269424823
Annuals > 3 > income Statement > total Other Income Expense Net
-259000000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
1366000000
Annuals > 3 > balance Sheet > short Term Investments
111000000
Annuals > 3 > balance Sheet > receivables
2609000000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
4763000000
Annuals > 3 > balance Sheet > property Plant Equipment
903000000
Annuals > 3 > balance Sheet > total Assets
24689000000
Annuals > 3 > balance Sheet > payables
621000000
Annuals > 3 > balance Sheet > short Term Debt
91000000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
18647000000
Annuals > 3 > balance Sheet > equity
6042000000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
966000000
Annuals > 3 > cash Flow > depreciation
1264000000
Annuals > 3 > cash Flow > change In Working Capital
680000000
Annuals > 3 > cash Flow > cash From Operations
2942000000
Annuals > 3 > cash Flow > capital Expenditures
640000000
Annuals > 3 > cash Flow > cash From Investing
-2103000000
Annuals > 3 > cash Flow > cash From Financing
-1235000000
Annuals > 3 > cash Flow > net Change In Cash
-448000000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
4.953846153846154
Annuals > 3 > ratios > PB
7.926837140019861
Annuals > 3 > ratios > ROE
15.988083416087386
Annuals > 3 > ratios > ROA
3.912673660334562
Annuals > 3 > ratios > FCF
2302000000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.16592186824275623
Annuals > 3 > health Score
55
Valuation > metrics > PE
0.4311
Valuation > metrics > PB
6.845980032467533
Valuation > final Score
40
Valuation > verdict
16.3% Overvalued
Profitability > metrics > ROE
5.373376623376623
Profitability > metrics > ROA
5.536042816524502
Profitability > metrics > Net Margin
0.08073170731707317
Profitability > final Score
39
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.642694805194805
Risk > metrics > Interest Coverage
2.925925925925926
Risk > final Score
18
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.0463773188659433
Liquidity > metrics > Quick Ratio
1.0463773188659433
Liquidity > final Score
76
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
32
Prev Profitabilities > 1
31
Prev Profitabilities > 2
53
Prev Risks > 0
17
Prev Risks > 1
18
Prev Risks > 2
21
Prev Liquidities > 0
84
Prev Liquidities > 1
81
Prev Liquidities > 2
100
Updated At
2026-01-22T21:23:00.099Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-05
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
3.4
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of IQVIA Holdings Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
3.4
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.